Is CURE or KMB a better dividend investment in 2026?

CURE currently yields 1.30% with a 5% 5-year dividend growth rate. KMB yields 4.00% with 5% growth. The better choice depends on your goal: KMB offers higher current income.

What is the dividend yield difference between CURE and KMB?

CURE has a forward dividend yield of 1.30% ($1.19/share annually). KMB yields 4.00% ($2.00/share annually). The yield gap is 2.70 percentage points.

Home › Compare › CURE vs KMB

CURE vs KMB: Dividend Comparison 2026

CURE yields 1.30% · KMB yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KMB wins by $6.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CURE

● Live price

1.30%

Share price

$91.57

Annual div

$1.19

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.5K

Annual income

$141.38

Full CURE calculator →

KMB

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full KMB calculator →

Portfolio growth — CURE vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CURE	KMB
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CURE + KMB cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CURE pays

KMB pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CURE

Annual income on $10K today (after 15% tax)

$110.46/yr

After 10yr DRIP, annual income (after tax)

$120.17/yr

KMB

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, KMB beats the other by $644.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CURE + KMB for your $10,000?

CURE: 50%KMB: 50%

100% KMB50/50100% CURE

Portfolio after 10yr

$24.8K

Annual income

$520.29/yr

Blended yield

2.10%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

CURE

No analyst data

KMB

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$123.00

+146.0% upside vs current

Range: $102.00 — $162.00

Altman Z

3.4

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CURE buys

KMB buys

No recent congressional trades found for CURE or KMB in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCUREKMB

Forward yield	1.30%	4.00% ✓
Annual dividend / share	$1.19	$2.00 ✓
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$21.5K	$28.0K ✓
Annual income after 10y	$141.38	$899.19 ✓
Total dividends collected	$1.4K	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: CURE vs KMB ($10,000, DRIP)

Year	CURE Portfolio	CURE Income/yr	KMB Portfolio	KMB Income/yr	Gap
1← crossover	$10,830	$129.96	$11,120	$420.00	$290.00 → KMB
2	$11,720	$131.53	$12,357	$458.31	$637.00 → KMB
3	$12,673	$133.03	$13,721	$499.76	$1.0K → KMB
4	$13,695	$134.44	$15,227	$544.58	$1.5K → KMB
5	$14,789	$135.77	$16,885	$593.02	$2.1K → KMB
6	$15,961	$137.03	$18,713	$645.34	$2.8K → KMB
7	$17,217	$138.22	$20,724	$701.81	$3.5K → KMB
8	$18,561	$139.33	$22,938	$762.73	$4.4K → KMB
9	$20,001	$140.39	$25,372	$828.41	$5.4K → KMB
10	$21,542	$141.38	$28,047	$899.19	$6.5K → KMB

CURE vs KMB: Complete Analysis 2026

CURE — Stock

The Direxion Daily Healthcare Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. There is no guarantee the fund will achieve its stated investment objectives.

Full CURE Calculator →

KMB — Consumer Staples

KMB is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in KMB shares.

Full KMB Calculator →

📬

Get this CURE vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CURE vs SCHD CURE vs JEPI CURE vs O CURE vs KO CURE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.